Suppr超能文献

T 滤泡辅助细胞在 SARS-CoV-2 感染和疫苗接种的体液免疫反应中的作用。

T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination.

机构信息

Department of Microbiology and Immunology, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.

Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Hospital and Central Clinical School, Monash University, Melbourne, Victoria, Australia.

出版信息

J Leukoc Biol. 2022 Feb;111(2):355-365. doi: 10.1002/JLB.5MR0821-464R. Epub 2021 Nov 3.

Abstract

Vaccination remains the most effective mechanism to reduce the impact of COVID-19. Induction of neutralizing antibodies is a strong correlate of protection from infection and severe disease. An understanding of the cellular events that underpin the generation of effective neutralizing antibodies is therefore key to the development of efficacious vaccines that target emerging variants of concern. Analysis of the immune response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and vaccination has identified circulating T follicular helper cells (cT ) as a robust correlate of the neutralizing antibody response. Here, we discuss the analysis of cT cells and their lymphoid counterparts in human humoral immune responses during COVID-19, and in response to vaccination with SARS-CoV-2 spike. We discuss the phenotypic heterogeneity of cT cells and the utility of cT subsets as informative biomarkers for development of humoral immunity. We posit that the analysis of the most effective cT will be critical to inducing durable immunity to new variants of SARS-CoV-2.

摘要

接种疫苗仍然是减少 COVID-19 影响的最有效机制。中和抗体的诱导是防止感染和严重疾病的强有力相关因素。因此,了解支持产生有效中和抗体的细胞事件对于开发针对新出现的关注变异株的有效疫苗至关重要。对严重急性呼吸系统综合征冠状病毒 2 (SARS-CoV-2) 感染和疫苗接种的免疫反应分析表明,循环滤泡辅助 T 细胞 (cT) 是中和抗体反应的有力相关因素。在这里,我们讨论了在 COVID-19 期间和对 SARS-CoV-2 刺突蛋白进行疫苗接种时,cT 细胞及其淋巴样对应物在人类体液免疫反应中的分析。我们讨论了 cT 细胞的表型异质性以及 cT 亚群作为体液免疫发展的信息生物标志物的实用性。我们假设,对最有效的 cT 的分析对于诱导对 SARS-CoV-2 新变异株的持久免疫力至关重要。

相似文献

1
T follicular helper cells in the humoral immune response to SARS-CoV-2 infection and vaccination.
J Leukoc Biol. 2022 Feb;111(2):355-365. doi: 10.1002/JLB.5MR0821-464R. Epub 2021 Nov 3.
2
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.
PLoS Pathog. 2021 Jul 16;17(7):e1009761. doi: 10.1371/journal.ppat.1009761. eCollection 2021 Jul.
7
Diverse BCR usage and T cell activation induced by different COVID-19 sequential vaccinations.
mBio. 2024 Oct 16;15(10):e0142924. doi: 10.1128/mbio.01429-24. Epub 2024 Sep 9.
9
High-affinity, neutralizing antibodies to SARS-CoV-2 can be made without T follicular helper cells.
Sci Immunol. 2022 Feb 4;7(68):eabl5652. doi: 10.1126/sciimmunol.abl5652.
10
TIGITTfh show poor B-helper function and negatively correlate with SARS-CoV-2 antibody titre.
Front Immunol. 2024 May 29;15:1395684. doi: 10.3389/fimmu.2024.1395684. eCollection 2024.

引用本文的文献

1
Vaccination with inactivated SARS-CoV-2 vaccine TURKOVAC induces durable humoral and cellular immune responses up to 8 months.
Front Med (Lausanne). 2025 Apr 28;12:1524393. doi: 10.3389/fmed.2025.1524393. eCollection 2025.
5
Immune responses to SARS-CoV-2 mRNA vaccination in people with idiopathic CD4 lymphopenia.
J Allergy Clin Immunol. 2024 Feb;153(2):503-512. doi: 10.1016/j.jaci.2023.10.012. Epub 2023 Oct 28.
7
Destabilisation of T cell-dependent humoral immunity in sepsis.
Clin Sci (Lond). 2024 Jan 10;138(1):65-85. doi: 10.1042/CS20230517.
9
Antigen-Specific CD4 T Cell and B Cell Responses to Borrelia burgdorferi.
J Immunol. 2023 Sep 15;211(6):994-1005. doi: 10.4049/jimmunol.2200890.
10
SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines.
Vaccines (Basel). 2023 Apr 15;11(4):849. doi: 10.3390/vaccines11040849.

本文引用的文献

1
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals.
Cell. 2022 Mar 17;185(6):1008-1024.e15. doi: 10.1016/j.cell.2022.01.027. Epub 2022 Feb 2.
2
SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans.
Cell. 2022 Feb 17;185(4):603-613.e15. doi: 10.1016/j.cell.2021.12.026. Epub 2021 Dec 23.
4
Rapid induction of antigen-specific CD4 T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccination.
Immunity. 2021 Sep 14;54(9):2133-2142.e3. doi: 10.1016/j.immuni.2021.08.001. Epub 2021 Aug 13.
5
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence.
PLoS Pathog. 2021 Jul 16;17(7):e1009761. doi: 10.1371/journal.ppat.1009761. eCollection 2021 Jul.
6
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation.
Clin Transl Immunology. 2021 Jul 5;10(7):e1306. doi: 10.1002/cti2.1306. eCollection 2021.
7
CD4 T cells that help B cells - a proposal for uniform nomenclature.
Trends Immunol. 2021 Aug;42(8):658-669. doi: 10.1016/j.it.2021.06.003. Epub 2021 Jul 6.
8
Evidence for antibody as a protective correlate for COVID-19 vaccines.
Vaccine. 2021 Jul 22;39(32):4423-4428. doi: 10.1016/j.vaccine.2021.05.063. Epub 2021 May 24.
9
SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses.
Nature. 2021 Aug;596(7870):109-113. doi: 10.1038/s41586-021-03738-2. Epub 2021 Jun 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验